Nick IaconiDirector, Government Pricing at Avyxa PharmaSpeaker
Profile
Nick Iaconi is Director of Strategic Planning and Government Pricing at Avyxa, where he leads government and strategic pricing, gross‑to‑net strategy, financial planning, Part B reimbursement forecasting, and regulatory and policy impact assessment.
With 14+ years in pharma and biotech, he brings deep expertise in government pricing, contracting, market access, gross‑to‑net optimization, FP&A, forecasting, reimbursement, and healthcare policy. Nick has supported rare and orphan drugs, specialty and specialty‑lite products, cell and gene therapies, biologics, biosimilars, and authorized generics across both pharmacy and medical benefits, evaluating the financial, operational, and market‑access implications of pricing and contracting decisions.
He is known for translating complex pricing, reimbursement, and policy issues into practical strategies that enable successful launches, sustainable access, and long‑term financial performance.
Agenda Sessions
Essential Agreements and Timelines for New Pharmaceutical Companies Preparing for Successful Drug
, 1:20pmView SessionMature Product Survival: Medicaid Negative Pricing and Post-AMP Cap Challenges
, 2:25pmView Session